Trial intelligence / Profile preview

Cholecalciferol in NAFLD and Type 2 Diabetes

NCT05613192Phase 3Unknown

Sponsor
Ain Shams University
Start
Oct 2022
Primary completion
Mar 2023
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of vitamin d in non-alcoholic fatty liver disease (NAFLD), sponsored by Ain Shams University. Status: unknown.

02

Drugs

vitamin d
03

Conditions

non-alcoholic fatty liver disease (NAFLD)

Beyond the preview

Go deeper on NCT05613192.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05613192.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call